Juan Jesús
Cruz Hernández
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario Gregorio Marañón (20)
2024
-
Indicators to evaluate quality of care in head and neck cancer in Spain
Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097
2023
-
Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 4
2021
-
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications
JCO oncology practice, Vol. 17, Núm. 8, pp. e1162-e1169
-
Laparoscopic pyelolithotomy in pelvic ectopic kidney: Case report and literature review
Actas Urologicas Espanolas, Vol. 45, Núm. 6, pp. 419-426
2019
-
Working towards a consensus on the oncological approach of breakthrough pain: A Delphi survey of Spanish experts
Journal of Pain Research, Vol. 12, pp. 2349-2358
2018
-
Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii612
-
First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183
-
Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study
Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 613-618
-
SEOM clinical guidelines for the treatment of head and neck cancer (2017)
Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 75-83
2017
-
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics
Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34
2016
-
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck
International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 2, pp. 289-296
-
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos
Revista de Psiquiatria y Salud Mental
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
2014
-
Análisis de impacto presupuestario del uso de fentanilo intranasal en pectina para el tratamiento del dolor irruptivo oncológico
Pharmacoeconomics - Spanish Research Articles, Vol. 11, Núm. 2, pp. 51-60
2013
-
Optimal management of breakthrough cancer pain (BCP)
Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 526-534
-
Relationship between the pharmacokinetic properties and efficacy of fentanyl pectin nasal spray in breakthrough cancer pain
Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 40-45
2012
-
Breakthrough cancer pain - Still a challenge
Journal of Pain Research, Vol. 5, pp. 559-566
-
Spanish Society of Medical Oncology (SEOM) Cancer and Thrombosis Working Group
Clinical and Translational Oncology
2010
-
Consensus document on the use of biosimilar granulocyte-colony stimulating factor for the correction of neutropenia associated in cancer patients
Farmacia Hospitalaria, Vol. 34, Núm. SUPPL. 1, pp. 45-50
2005
-
Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer
Investigational New Drugs, Vol. 23, Núm. 3, pp. 243-251